ILMN Illumina Inc Company Projected Revenue

Illumina Corp - graphic logo of issuer ILMN

Illumina, Inc. (ILMN) dominates the NGS systems segment, generating revenue through the sale of consumables via a "razor-and-blade" model. Leadership in genome sequencing has made personalized medicine accessible, a fact confirmed by the company's future sales trend on the GURU.Markets chart. A stable patent moat and the restructuring of Grail support the business, while the value of 4.78 captures the metric level.

Company Projected Revenue: illumina.com (ILMN) for 07/04/2022 - 11/18/2026

Metric breakdowns and analytics for Illumina Corp (ILMN)

- stock quotes and analyst forecast:
Basic company analysis:ILMN Illumina Corp
Signature product of Illumina Inc

This indicator aggregates revenue forecast models, promptly reflecting shifts in market expectations regarding the company's future cash flows. A decline in this metric may indicate either a fundamental crisis or a temporary undervaluation, which, within the context of the defensive business of Illumina, Inc. (ILMN) and its government support, allows the future sales volume dynamics on GURU.Markets to distinguish cyclical volatility from a systemic downturn.

Who Illumina, Inc. competes with

Company Projected Revenue Agilent (A)|Projected Sales Volume Quest Diagnostics Incorporated (DGX)|Exact Sciences - Company Future Sales Volume|Revvity, Inc. (RVTY) - Company Expected Sales Volume|BIO: Company Future Sales Volume|NNNN: Company Projected Revenue|Sotera Health (SHC) - Company Projected Revenue|Company Revenue Forecast QDEL|OPK (OPKO Corp) - Projected Sales Volume|Company Revenue Forecast CDNA (CareDx, Inc)|Projected Sales Volume MRVI|Fulgent Genetics - Company Revenue Forecast|Projected Sales Volume LAB (Fluidigm)|Cytek Biosciences - Company Projected Revenue|OSUR: Company Future Sales Volume|XGN (exagen.com) - Company Revenue Forecast|MDXH: Projected Sales Volume|Lucid Diagnostics Inc. (LUCD) - Projected Sales Volume|PRE (Prenetics Global) - Projected Sales Volume|Company Expected Sales Volume imdxinc.com IMDX|Company Projected Revenue Trinity Biotech plc (TRIB)|Projected Sales Volume ProPhase (PRPH)|Projected Sales Volume AIMD (ainos.com)|Company Future Sales Co-Diagnostics, Inc. (CODX)|heartsciences.com - Projected Sales Volume|Biomerica, Inc (BMRA) - Company Future Sales Volume|Cardio Diagnostics (CDIO) - Company Projected Revenue|ONCO - Company Future Sales|VRAX (Virax Biolabs Corp) - Projected Sales Volume|Bluejay Diagnostics, Inc. (BJDX) - Company Future Sales|Projected Sales Volume AWH|Accelerate Diagnostics Inc. - Company Revenue Forecast|Centogene - Company Future Sales Volume|Enzo Biochem, Inc. (ENZ) - Company Expected Sales Volume|Company Projected Revenue Volume Fresh2 Group Limited FRES|Company Future Sales gtglabs.com GENE|23andMe Holding Co (ME) - Company Projected Revenue|Company Revenue Forecast PMD